JP2002515249A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002515249A5 JP2002515249A5 JP2000549738A JP2000549738A JP2002515249A5 JP 2002515249 A5 JP2002515249 A5 JP 2002515249A5 JP 2000549738 A JP2000549738 A JP 2000549738A JP 2000549738 A JP2000549738 A JP 2000549738A JP 2002515249 A5 JP2002515249 A5 JP 2002515249A5
- Authority
- JP
- Japan
- Prior art keywords
- peptides
- composition
- peptide
- amino acid
- library
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 69
- 239000000203 mixture Substances 0.000 description 50
- 238000000034 method Methods 0.000 description 45
- 102000004196 processed proteins & peptides Human genes 0.000 description 41
- 125000003275 alpha amino acid group Chemical group 0.000 description 15
- 102000039446 nucleic acids Human genes 0.000 description 15
- 108020004707 nucleic acids Proteins 0.000 description 15
- 150000007523 nucleic acids Chemical class 0.000 description 15
- 230000004927 fusion Effects 0.000 description 11
- 101000666856 Homo sapiens Vasoactive intestinal polypeptide receptor 1 Proteins 0.000 description 9
- 102100038388 Vasoactive intestinal polypeptide receptor 1 Human genes 0.000 description 9
- 239000002245 particle Substances 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 241001515965 unidentified phage Species 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 2
- 238000012258 culturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810756.8A GB9810756D0 (en) | 1998-05-19 | 1998-05-19 | Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| GB9810756.8 | 1998-05-19 | ||
| PCT/EP1999/003344 WO1999060132A1 (en) | 1998-05-19 | 1999-05-14 | Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002515249A JP2002515249A (ja) | 2002-05-28 |
| JP2002515249A5 true JP2002515249A5 (enExample) | 2006-05-18 |
| JP4593780B2 JP4593780B2 (ja) | 2010-12-08 |
Family
ID=10832337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000549738A Expired - Fee Related JP4593780B2 (ja) | 1998-05-19 | 1999-05-14 | Ｈｃｖのｅ２糖タンパク質の超可変部１のミモトープおよびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7034108B1 (enExample) |
| EP (1) | EP1002092B1 (enExample) |
| JP (1) | JP4593780B2 (enExample) |
| KR (1) | KR20010022026A (enExample) |
| CN (1) | CN1274387A (enExample) |
| AT (1) | ATE308618T1 (enExample) |
| AU (1) | AU766610B2 (enExample) |
| CA (1) | CA2297408C (enExample) |
| DE (1) | DE69928064T2 (enExample) |
| DK (1) | DK1002092T3 (enExample) |
| ES (1) | ES2251832T3 (enExample) |
| GB (1) | GB9810756D0 (enExample) |
| WO (1) | WO1999060132A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2809402A1 (fr) * | 2000-05-26 | 2001-11-30 | Dev Des Antigenes Combinatoire | Bibliotheques peptidiques combinatoires convergentes et leur application a la vaccination contre le virus de l'hepatite c |
| EP1290230A4 (en) * | 2000-06-02 | 2004-10-20 | Merck & Co Inc | HEPATITIS C VIRUS CONJUGATE |
| WO2002045743A2 (en) * | 2000-12-09 | 2002-06-13 | Cambridge University Technical Services Limited | Hcv vaccines |
| JP4475561B2 (ja) | 2001-10-11 | 2010-06-09 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｃ型肝炎ウイルスワクチン |
| EP2172552A3 (en) | 2001-10-11 | 2010-07-21 | Merck Sharp & Dohme Corp. | Recombinant nucleic acids comprising regions of AD6 |
| CN1305898C (zh) * | 2003-08-22 | 2007-03-21 | 中国科学院上海生命科学研究院 | 丙型肝炎病毒被膜蛋白hvr1模拟多肽、其编码基因及用途 |
| EP1893636A2 (en) | 2005-06-17 | 2008-03-05 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Hepatitis c virus nucleic acid vaccine |
| JP5031827B2 (ja) * | 2006-06-01 | 2012-09-26 | 程云 | 予防或いは肝損傷を治療するペプチッド |
| WO2007146975A2 (en) * | 2006-06-13 | 2007-12-21 | Athenix Corporation | Methods for generating genetic diversity by permutational mutagenesis |
| BRPI0719672A2 (pt) | 2006-11-29 | 2013-12-24 | Athenix Corp | Molécula isolada de ácido nucleico, vetor, célula hospedeira, planta transgênica, semente transgênica, polipeptídeo isolado, método para produzir um polipeptídeo com atividade de resistência a herbicidas, método para conferir resistência a um herbicida em uma planta, planta, método para aumentar o vigor ou rendimento de uma planta, método para conferir resistência ao glifosato a uma planta |
| CN110078800B (zh) * | 2019-04-24 | 2021-01-29 | 中国人民解放军第二军医大学 | 合成肽在制备防治肝炎病毒感染药物中的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2067194C (en) | 1989-10-05 | 2003-03-18 | Glenn Kawasaki | Cell-free synthesis and isolation of novel genes and polypeptides |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| IT1270939B (it) | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
| ATE249838T1 (de) | 1993-05-12 | 2003-10-15 | Chiron Corp | Konserviertes motiv der hepatitis c virus e2/ns1 region |
| AU8124694A (en) | 1993-10-29 | 1995-05-22 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| US5492807A (en) | 1993-11-19 | 1996-02-20 | Santi; Daniel V. | Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| US6110465A (en) * | 1995-06-07 | 2000-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
| JPH11124398A (ja) * | 1997-10-22 | 1999-05-11 | Japan Energy Corp | Ｃ型肝炎ウイルス由来の抗原ペプチドとそれを用いる抗体検査薬 |
-
1998
- 1998-05-19 GB GBGB9810756.8A patent/GB9810756D0/en not_active Ceased
-
1999
- 1999-05-14 JP JP2000549738A patent/JP4593780B2/ja not_active Expired - Fee Related
- 1999-05-14 US US09/463,098 patent/US7034108B1/en not_active Expired - Fee Related
- 1999-05-14 WO PCT/EP1999/003344 patent/WO1999060132A1/en not_active Ceased
- 1999-05-14 CA CA2297408A patent/CA2297408C/en not_active Expired - Fee Related
- 1999-05-14 EP EP99924978A patent/EP1002092B1/en not_active Expired - Lifetime
- 1999-05-14 AT AT99924978T patent/ATE308618T1/de active
- 1999-05-14 DE DE69928064T patent/DE69928064T2/de not_active Expired - Lifetime
- 1999-05-14 AU AU41435/99A patent/AU766610B2/en not_active Ceased
- 1999-05-14 CN CN99801173A patent/CN1274387A/zh active Pending
- 1999-05-14 DK DK99924978T patent/DK1002092T3/da active
- 1999-05-14 ES ES99924978T patent/ES2251832T3/es not_active Expired - Lifetime
- 1999-05-14 KR KR1020007000594A patent/KR20010022026A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6306625B1 (en) | Method for obtaining expression of mixed polypeptide particles in yeast | |
| Meola et al. | Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. | |
| JP2758184B2 (ja) | 肝炎ｂ表面抗原ワクチン | |
| JP2002520000A5 (enExample) | ||
| CA2331846A1 (en) | Expression vectors for stimulating an immune response and methods of using the same | |
| JP2012501959A5 (enExample) | ||
| CA2325566A1 (en) | Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates | |
| JPH07502642A (ja) | 新規な形態のリポ糖結合性タンパク質（ｌｂｐ） | |
| JP2001069969A (ja) | 病原性ボレリア・ブルグドルフェリ菌株、病原性ボレリア・ブルグドルフェリの単離及び再培養法 | |
| JPH05262667A (ja) | ウイルス抗原を用いるワクチン | |
| JP2002515249A5 (enExample) | ||
| JPH0327400A (ja) | Ｂ型肝炎ウイルスコア抗原粒子 | |
| CN112062862A (zh) | 疫苗通用载体及其制备方法和应用 | |
| JP2004504067A (ja) | 改良されたウイルス様粒子 | |
| JP2002517249A5 (enExample) | ||
| JPH05506247A (ja) | ヒトγインターフェロンのアンタゴニスト | |
| CN120248057A (zh) | 一种呼吸道合胞病毒f蛋白突变体及其应用 | |
| JPH02503916A (ja) | Ｈｉｖエンベロープ蛋白質に関連する合成ペプチド | |
| CA2297408A1 (en) | Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof | |
| Scheerlinck et al. | Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein | |
| EP3517542B1 (en) | Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide | |
| CA2272051A1 (en) | Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation | |
| JP2007300856A (ja) | アミロイドタンパク質模倣物 | |
| JPH02223594A (ja) | ヒトライノウイルスペプチド | |
| AU605574B2 (en) | Human rhinovirus peptides |